A drug used to treat leukemia can enhance the efficacy of immunotherapy for lung cancer, researchers at National Taiwan University Hospital (NTUH) found, saying that the discovery might increase the life expectancy of those with the disease.
The team led by Tsai Hsing-chen (蔡幸真), a doctor in the hospital’s internal medicine department, told a news conference in Taipei on Thursday that new treatments for lung cancer are urgently needed, adding that the disease kills more than 9,000 people per year in Taiwan, as it is often discovered at a late stage.
People with advanced lung cancer have in the past few years increasingly received immunotherapy, which seeks to boost the body’s immune defenses and has fewer side effects than chemotherapy, Tsai said.
However, immunotherapy is only suitable for about 50 percent of people with lung cancer, with long-lasting results for about 30 percent of those who receive it, NTUH thoracic oncology department director Shih Jin-yuan (施金元) said.
The hospital’s four-year research project sought to make immunotherapy an option for more people with the disease and increase its efficacy, NTUH said.
The team found that decitabine, a drug that blocks the activity of enzymes that facilitate the spread of cancer cells in myeloid leukemia patients, also increases the number of a certain type of receptor on the surface of lung cancer cells, Tsai said.
This made the cancer cells more vulnerable to the immune system’s gamma delta T cells, she added.
Although there is a limited number of gamma delta T cells in the body, the cells can be cultivated in the laboratory and administered together with decitabine, Tsai said.
In experiments on mice, the team found that the treatment reduced the size of lung tumors and increased life expectancy, she said.
The hospital is planning to apply for clinical trials, Tsai said, adding that similar treatments could be developed for other types of cancer, including colon and ovarian cancer.
The researchers’ findings were published in the peer-reviewed journal Nature Communications on Monday last week.
The first global hotel Keys Selection by the Michelin Guide includes four hotels in Taiwan, Michelin announced yesterday. All four received the “Michelin One Key,” indicating guests are to experience a “very special stay” at any of the locations as the establishments are “a true gem with personality. Service always goes the extra mile, and the hotel provides much more than others in its price range.” Of the four hotels, three are located in Taipei and one in Taichung. In Taipei, the One Key accolades were awarded to the Capella Taipei, Kimpton Da An Taipei and Mandarin Oriental Taipei. Capella Taipei was described by
The Taichung District Court yesterday confirmed its final ruling that the marriage between teenage heir Lai (賴) and a man surnamed Hsia (夏) was legally invalid, preventing Hsia from inheriting Lai’s NT$500 million (US$16.37 million) estate. The court confirmed that Hsia chose not to appeal the civil judgement after the court handed down its ruling in June, making the decision final. In the June ruling, the court said that Lai, 18, and Hsia, 26, showed “no mutual admiration before the marriage” and that their interactions were “distant and unfamiliar.” The judge concluded that the couple lacked the “true intention of
EVA Airways today confirmed the death of a flight attendant on Saturday upon their return to Taiwan and said an internal investigation has been launched, as criticism mounted over a social media post accusing the airline of failing to offer sufficient employee protections. According to the post, the flight attendant complained of feeling sick on board a flight, but was unable to take sick leave or access medical care. The crew member allegedly did not receive assistance from the chief purser, who failed to heed their requests for medical attention or call an ambulance once the flight landed, the post said. As sick
INDUSTRY: Beijing’s latest export measures go beyond targeting the US and would likely affect any country that uses Chinese rare earths or related tech, an academic said Taiwanese industries could face significant disruption from China’s newly tightened export controls on rare earth elements, as much of Taiwan’s supply indirectly depends on Chinese materials processed in Japan, a local expert said yesterday. Kristy Hsu (徐遵慈), director of the Taiwan ASEAN Studies Center at the Chung-Hua Institution for Economic Research, said that China’s latest export measures go far beyond targeting the US and would likely affect any country that uses Chinese rare earths or related technologies. With Japan and Southeast Asian countries among those expected to be hit, Taiwan could feel the impact through its reliance on Japanese-made semi-finished products and
RSS